Exact Mass: 482.0519

Lentinic acid

C12H22N2O10S4 (482.0157)

Lentinic acid is found in mushrooms. Lentinic acid is isolated from the mushroom Lentinus edodes. Isolated from the mushroom Lentinus edodes. Lentinic acid is found in mushrooms.

2,3-(S)-hexahydroxydiphenoyl-D-glucose

C20H18O14 (482.0697)

3,4,5,11,12,13,21,22,23-nonahydroxy-9,14,17-trioxatetracyclo[17.4.0.0(2),.0(1),(1)]tricosa-1(23),2,4,6,19,21-hexaene-8,18-dione

C20H18O14 (482.0697)

6,7,8,11,12,13,21,22,23-nonahydroxy-2,17,20-trioxatetracyclo[17.3.1.0,.0(1),(1)]tricosa-4,6,8,10,12,14-hexaene-3,16-dione

C20H18O14 (482.0697)

Regorafenib

C21H15ClF4N4O3 (482.0769)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Regorafenib (BAY 73-4506) is an orally active and potent multi-targeted receptor tyrosine kinase inhibitor, with IC50 values of 13/4.2/46, 22, 7, 1.5 and 2.5 nM for VEGFR1/2/3, PDGFRβ, Kit, RET and Raf-1, respectively. Regorafenib shows very robust antitumor and antiangiogenic activity[1].

Seletalisib

C23H14ClF3N6O (482.087)

Flustramine J

C21H28Br2N2O (482.0568)

Falconensin A

C23H24Cl2O7 (482.0899)

CHEMBL2392772

C21H19Cl2F3N6 (482.1)

ZINC2161256

C21H12F6N4OS (482.0636)

2-(alpha-Hydroxypropyl)thiamine diphosphate; 2-Hydroxypropyl-ThPP

C15H24N4O8P2S (482.079)

degalloyl-punicacortein A

C20H18O14 (482.0697)

NSC291853

C27H14O9 (482.0638)

amurensin O

C28H18O8 (482.1002)

4,6-(S)-HHDP-D-glucose|4,6-O-((S)-4,4,5,5,6,6-hexahydroxydiphenoyl)-D-glucose|4,6-O-<(S)-4,4,5,5,6,6-hexahydroxydiphenoyl>-D-glucose

C20H18O14 (482.0697)

Triumbelletin

C27H14O9 (482.0638)

Wikstrosin

C27H14O9 (482.0638)

Fucodiphlorethol C

C24H18O11 (482.0849)

Arsenosugar 482

C13H28AsO12P (482.0534)

fucodiphloroethol G

C24H18O11 (482.0849)

Regorafenib (BAY 73-4506)

C21H15ClF4N4O3 (482.0769)

LENTINIC ACID

C12H22N2O10S4 (482.0157)

2-(4-Iodophenyl)-4,5-bis(4-methoxyphenyl)-1H-imidazole

C23H19IN2O2 (482.0491)

5-((4-BROMO-2-CHLOROPHENYL)AMINO)-4-FLUORO-1-METHYL-N-(2-(VINYLOXY)ETHOXY)-1H-BENZO[D]IMIDAZOLE-6-CARBOXAMIDE

C19H17BrClFN4O3 (482.0157)

(-)-1 6-BIS(2-CHLOROPHENYL)-1 6-DIPHENY&

C30H20Cl2O2 (482.084)

Ferrous gluconate dihydrate

C12H26FeO16 (482.057)

B - Blood and blood forming organs > B03 - Antianemic preparations > B03A - Iron preparations > B03AA - Iron bivalent, oral preparations D006401 - Hematologic Agents > D006397 - Hematinics

BIS(1,5-CYCLOOCTADIENE)DIMETHOXYDIRHODIUM

C18H28O2Rh2 (482.0199)

(-)-1,2-BIS((2S,5S)-2,5-DIETHYLPHOSPHOLANO)ETHANE

C30H20Cl2O2 (482.084)

2-Naphthalenesulfonic acid, 6-hydroxy-5-[2-(2-methoxy-5-methyl-4- sulfophenyl)diazenyl]-, aluminum salt (1:1)

C18H19AlN2O8S2 (482.0398)

Lead(II) salicylate

C14H10O6Pb (482.0244)

3-bromo-7,12-diphenylbenzo[k]fluoranthene

C32H19Br (482.067)

bis(3,4-dimethylphenyl)iodanium,hexafluorophosphate

C16H18F6IP (482.0095)

4-[2-(4-carboxy-3-nitrophenyl)-1,1,1,3,3,3-hexafluoropropan-2-yl]-2-nitrobenzoic acid

C17H8F6N2O8 (482.0185)

cis-[2-(2,4-Dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methyl-4-methylbenzenesulphonate

C21H20Cl2N2O5S (482.047)

Seletalisib

C23H14ClF3N6O (482.087)

C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor

Disperse Brown 19

C20H20Cl2N4O6 (482.076)

(2-NAPHTHYLMETHYL)(TRIPHENYL)PHOSPHONIUM BROMIDE

C29H24BrP (482.0799)

[3,3,4,4,5,5,6,6,7,8,8,8-dodecafluoro-7-(trifluoromethyl)octyl] 2-methylprop-2-enoate

C13H9F15O2 (482.0363)

1,4-Bis[3-(2-pyridyldithio)propionamido]butane

C20H26N4O2S4 (482.0939)

2-(4-(2-((3-(5-(Pyridin-2-Ylthio)thiazol-2-Yl)ureido)methyl)-1h-Imidazol-4-Yl)phenoxy)acetic Acid

C21H18N6O4S2 (482.0831)

Regorafenib

C21H15ClF4N4O3 (482.0769)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Regorafenib (BAY 73-4506) is an orally active and potent multi-targeted receptor tyrosine kinase inhibitor, with IC50 values of 13/4.2/46, 22, 7, 1.5 and 2.5 nM for VEGFR1/2/3, PDGFRβ, Kit, RET and Raf-1, respectively. Regorafenib shows very robust antitumor and antiangiogenic activity[1].

2,3-Dihydroxybenzoyl 5-adenylate(1-)

C17H17N5O10P- (482.0713)

Conjugate base of 2,3-dihydroxybenzoyl 5-adenylate.

8-Carboxy-8-demethylriboflavin 5-phosphate

C17H15N4O11P-4 (482.0475)

(3,4-Dihydroxybenzoate)adenylate

C17H17N5O10P- (482.0713)

4-O-sulfo-beta-D-galactopyranosyl-(1->4)-3,6-anhydro-2-O-sulfo-D-galactose

C12H18O16S2-2 (482.0036)

2,6-dichloro-3-(glutathion-S-yl)-hydroquinone

C16H18Cl2N3O8S- (482.0192)

3,6-anhydro-2-O-sulfo-alpha-D-galactopyranosyl-(1->3)-4-O-sulfo-D-galactose

C12H18O16S2-2 (482.0036)

Arseno sugar 2

C13H28AsO12P (482.0534)

[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] 3-amino-4-hydroxybenzoate

C17H19N6O9P (482.0951)

2-[(2,6-dichlorophenyl)sulfonylamino]-3-methylbutanoic acid [2-(1H-indol-3-yl)-2-oxoethyl] ester

C21H20Cl2N2O5S (482.047)

4-(4-chlorophenyl)sulfonyl-5-(3,4-dihydro-1H-isoquinolin-2-yl)-2-ethylsulfonylthiazole

C20H19ClN2O4S3 (482.0195)

2-Phenyl-5-thiophen-2-yl-3-pyrazolecarboxylic acid [2-(4-chloro-3-nitroanilino)-2-oxoethyl] ester

C22H15ClN4O5S (482.0452)

2-Phenyl-5-thiophen-2-yl-3-pyrazolecarboxylic acid [2-(2-chloro-5-nitroanilino)-2-oxoethyl] ester

C22H15ClN4O5S (482.0452)

2-[1-(4-chlorophenyl)-5-oxo-3-(2-pyridin-4-ylethyl)-2-sulfanylidene-4-imidazolidinyl]-N-(4-fluorophenyl)acetamide

C24H20ClFN4O2S (482.0979)

N-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]-5-(2-pyridinyl)-2-thiophenesulfonamide

C18H12F6N2O3S2 (482.0194)

6-Bromo-4-[(dimethylamino)methyl]-5-hydroxy-1-methyl-2-[(thiophen-2-ylthio)methyl]-3-indolecarboxylic acid ethyl ester

C20H23BrN2O3S2 (482.0333)

2-hydroxy-4-[4-[(5Z)-5-[(Z)-2-methyl-3-phenylprop-2-enylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]butanoylamino]benzoic acid

C24H22N2O5S2 (482.097)

[2-[5,7-Dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-8-yl]-4,5-dihydroxyoxan-3-yl] hydrogen sulate

C20H18O12S (482.0519)

[2-(acetyloxy)-2-(9-{[(2E)-2-methylbut-2-enoyl]oxy}-2-oxo-2H,8H,9H-furo[2,3-h]chromen-8-yl)propoxy]sulfonic acid

C21H22O11S (482.0883)

(7r,8s,8as)-8-hydroxy-7-methyl-6-oxo-3-[(1e)-prop-1-en-1-yl]-8,8a-dihydro-1h-isochromen-7-yl 3,5-dichloro-2,4-dimethoxy-6-methylbenzoate

C23H24Cl2O7 (482.0899)

7,7'-dihydroxy-3-[(2-oxochromen-7-yl)oxy]-[8,8'-bichromene]-2,2'-dione

C27H14O9 (482.0638)

(10r,11r,13r,14r,15s)-3,4,5,11,14,20,21,22-octahydroxy-13-(hydroxymethyl)-9,12,16-trioxatetracyclo[16.4.0.0²,⁷.0¹⁰,¹⁵]docosa-1(18),2,4,6,19,21-hexaene-8,17-dione

C20H18O14 (482.0697)

(10r,11s,13r,14r,15s)-3,4,5,11,14,20,21,22-octahydroxy-13-(hydroxymethyl)-9,12,16-trioxatetracyclo[16.4.0.0²,⁷.0¹⁰,¹⁵]docosa-1(18),2,4,6,19,21-hexaene-8,17-dione

C20H18O14 (482.0697)

2,3-hexahydroxydiphenyl-D-glucose

C20H18O14 (482.0697)

{"Ingredient_id": "HBIN004100","Ingredient_name": "2,3-hexahydroxydiphenyl-D-glucose","Alias": "NA","Ingredient_formula": "C20H18O14","Ingredient_Smile": "C1=C2C(=C(C(=C1O)O)O)C3=C(C(=C(C=C3C(=O)OC4C(C(C(OC4O)CO)O)OC2=O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "42628","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

2,3-o-(s)-hexahydroxydiphenoyl-d-gluco-pyranose

C20H18O14 (482.0697)

{"Ingredient_id": "HBIN004147","Ingredient_name": "2,3-o-(s)-hexahydroxydiphenoyl-d-gluco-pyranose","Alias": "NA","Ingredient_formula": "C20H18O14","Ingredient_Smile": "C1=C2C(=C(C(=C1O)O)O)C3=C(C(=C(C=C3C(=O)OC4C(C(C(OC4O)CO)O)OC2=O)O)O)O","Ingredient_weight": "482.3 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15749","TCMID_id": "9501","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "14035453","DrugBank_id": "NA"}

(10s,11r,12r,13r,15r)-3,4,5,11,12,13,21,22,23-nonahydroxy-9,14,17-trioxatetracyclo[17.4.0.0²,⁷.0¹⁰,¹⁵]tricosa-1(19),2,4,6,20,22-hexaene-8,18-dione

C20H18O14 (482.0697)

(3r,11r)-3,11-bis(3,4-dihydroxyphenyl)-4,12-dioxapentacyclo[8.6.1.1²,⁵.0¹³,¹⁷.0⁹,¹⁸]octadeca-1,5(18),6,8,10(17),13,15-heptaene-7,15-diol

C28H18O8 (482.1002)

5'-[2,4-dihydroxy-6-(2,4,6-trihydroxyphenoxy)phenoxy]-[1,1'-biphenyl]-2,3',4,6-tetrol

C24H18O11 (482.0849)

(2r)-2,3-dihydroxypropoxy((2s)-3-{[(2r,3r,4s,5s)-5-[(dimethylarsoryl)methyl]-3,4-dihydroxyoxolan-2-yl]oxy}-2-hydroxypropoxy)phosphinic acid

C13H28AsO12P (482.0534)

[(6s,8as)-8a-(chloromethyl)-8-hydroxy-1-methyl-2,5-dioxo-3h,6h-imidazo[1,2-a]pyrazin-6-yl]methyl 2,3-dihydroxy-2-(hydroxymethyl)-1,4-benzoxazine-5-carboxylate

C19H19ClN4O9 (482.0841)

3,4,5,11,12,13,21,22,23-nonahydroxy-9,14,17-trioxatetracyclo[17.4.0.0²,⁷.0¹⁰,¹⁵]tricosa-1(19),2,4,6,20,22-hexaene-8,18-dione

C20H18O14 (482.0697)

4-chloro-5-[2-chloro-4-(2-chloro-6-methylphenoxy)-3,5,6-trimethylphenoxy]-3-methoxybenzene-1,2-diol

C23H21Cl3O5 (482.0455)

7'-hydroxy-7-[(7-hydroxy-2-oxochromen-3-yl)oxy]-[6,8'-bichromene]-2,2'-dione

C27H14O9 (482.0638)

5,7-dibromo-3a-(3,7-dimethylocta-2,6-dien-1-yl)-1-methyl-2h,3h,8h,8ah-pyrrolo[2,3-b]indol-4-ol

C21H28Br2N2O (482.0568)

8-hydroxy-7-methyl-6-oxo-3-(prop-1-en-1-yl)-8,8a-dihydro-1h-isochromen-7-yl 3,5-dichloro-2,4-dimethoxy-6-methylbenzoate

C23H24Cl2O7 (482.0899)

3,4,5,11,14,20,21,22-octahydroxy-13-(hydroxymethyl)-9,12,16-trioxatetracyclo[16.4.0.0²,⁷.0¹⁰,¹⁵]docosa-1(22),2(7),3,5,18,20-hexaene-8,17-dione

C20H18O14 (482.0697)

(1s,19r,21s,22r,23r)-6,7,8,11,12,13,21,22,23-nonahydroxy-2,17,20-trioxatetracyclo[17.3.1.0⁴,⁹.0¹⁰,¹⁵]tricosa-4,6,8,10(15),11,13-hexaene-3,16-dione

C20H18O14 (482.0697)

2,3-dihydroxypropoxy(3-({5-[(dimethylarsoryl)methyl]-3,4-dihydroxyoxolan-2-yl}oxy)-2-hydroxypropoxy)phosphinic acid

C13H28AsO12P (482.0534)

7-hydroxy-7'-[(7-hydroxy-2-oxochromen-3-yl)oxy]-[6,8'-bichromene]-2,2'-dione

C27H14O9 (482.0638)

(14s,15r,19r)-2,3,4,7,8,9,19-heptahydroxy-14-[(1r,2r)-1,2,3-trihydroxypropyl]-13,16-dioxatetracyclo[13.3.1.0⁵,¹⁸.0⁶,¹¹]nonadeca-1,3,5(18),6(11),7,9-hexaene-12,17-dione

C20H18O14 (482.0697)

2,3,4,7,8,9,19-heptahydroxy-14-(1,2,3-trihydroxypropyl)-13,16-dioxatetracyclo[13.3.1.0⁵,¹⁸.0⁶,¹¹]nonadeca-1,3,5(18),6(11),7,9-hexaene-12,17-dione

C20H18O14 (482.0697)

6,7,8,11,12,13,21,22,23-nonahydroxy-2,17,20-trioxatetracyclo[17.3.1.0⁴,⁹.0¹⁰,¹⁵]tricosa-4,6,8,10(15),11,13-hexaene-3,16-dione

C20H18O14 (482.0697)

(3as,8as)-5,7-dibromo-3a-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-1-methyl-2h,3h,8h,8ah-pyrrolo[2,3-b]indol-4-ol

C21H28Br2N2O (482.0568)

(10r,13r,14r,15s)-3,4,5,11,14,20,21,22-octahydroxy-13-(hydroxymethyl)-9,12,16-trioxatetracyclo[16.4.0.0²,⁷.0¹⁰,¹⁵]docosa-1(18),2,4,6,19,21-hexaene-8,17-dione

C20H18O14 (482.0697)

(2s,3s,4r,5s)-2-{[5,8-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxy}-4,5-dihydroxyoxan-3-yl sulfonate

C20H18O12S (482.0519)